To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MTMR14TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
508 supporting clones for gene MTMR14 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_001077525.2   .a 1 to 2525 1 to 2525 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2525/2525
(100 %)
0 diff
(100 %id)
AK074792   .a 30 to 2523 1 to 2494 F390S tiling clone, available from FLJ,   2494/2494
(100 %)
1 diff
(100.0 %id)
BX353896 Neuroblastoma Cot 25-normalized .a 34 to 973 1 to 940       940/940
(100 %)
1 diff
(99.9 %id)
AL523357 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 45 to 1021 32 to 999       973/1030
(94 %)
11 diff
(99.0 %id)
BC025952 Eye, normal, pigmented retinal epithelium .a 51 to 2519 1 to 2469 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2469/2469
(100 %)
0 diff
(100 %id)
AL516704 brain, neuroblastoma, neuroblastoma cells .a 62 to 856 1 to 794       794/794
(100 %)
1 diff
(99.9 %id)
BG682735 brain, neuroblastoma, cell line .a 82 to 569 1 to 493       493/809
(60 %)
13 diff
(98.4 %id)
BC035690 Blood, adult leukocytes .a 89 to 2523 1 to 2435 exact available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2435/2435
(100 %)
0 diff
(100 %id)
BM050517 eye, normal pigmented retinal epithelium .a 975 to 1839 1 to 866       866/866
(100 %)
23 diff
(97.4 %id)
BQ641465 eye, normal pigmented retinal epithelium .a 978 to 1907 1 to 950       950/951
(99 %)
49 diff
(94.9 %id)
TI_1948147664   .a 1202 to 2108 1020 to 118       903/1208
(74 %)
14 diff
(98.9 %id)
TI_1948147336   .a 1273 to 2108 967 to 120       844/1317
(64 %)
28 diff
(97.9 %id)
TI_1948147019   .a 1317 to 2108 915 to 119       797/1272
(62 %)
19 diff
(98.6 %id)
BP306412   .a 1326 to 1896 1 to 570       570/570
(100 %)
2 diff
(99.7 %id)
N77394 multiple sclerosis lesions .a 1337 to 1833 1 to 500       500/502
(99 %)
16 diff
(96.9 %id)
AY545552 melanoma .a 1364 to 1821 7 to 463       457/465
(98 %)
3 diff
(99.4 %id)
CD672371 eye, Iris .a 1407 to 1821 1 to 414       414/418
(99 %)
3 diff
(99.3 %id)
TI_1948147335   .a 1444 to 2108 784 to 119       666/1191
(55 %)
9 diff
(99.3 %id)
TI_1948147663   .a 1444 to 2108 787 to 115       673/1236
(54 %)
17 diff
(98.7 %id)
TI_1948147990   .a 1446 to 2108 784 to 119       666/1201
(55 %)
11 diff
(99.1 %id)
TI_1948147991   .a 1446 to 2108 782 to 120       663/1313
(50 %)
3 diff
(99.8 %id)
Z43872 brain, total brain .a 1451 to 1779 1 to 329       329/329
(100 %)
2 diff
(99.4 %id)
BX353895 Neuroblastoma Cot 25-normalized .a 1451 to 2495 1041 to 4       1038/1041
(99 %)
7 diff
(99.4 %id)
BX343335   .a 1451 to 2494 1030 to 1       1030/1031
(99 %)
23 diff
(97.8 %id)
H12922 whole brain .a 1452 to 1893 1 to 444       444/444
(100 %)
19 diff
(95.8 %id)
BE074247 breast .a 1474 to 1921 447 to 2     Submitted on the opposite strand 446/447
(99 %)
2 diff
(99.6 %id)
AL562194 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .a 1489 to 2512 1017 to 1       1017/1049
(96 %)
22 diff
(98.0 %id)
BG492086 amelanotic melanoma, cell line, skin .a 1556 to 2471 916 to 2       918/920
(99 %)
11 diff
(98.9 %id)
BE019432 muscle, rhabdomyosarcoma .a 1627 to 2124 1 to 498   fully sequenced,   498/498
(100 %)
0 diff
(100 %id)
AL516703 brain, neuroblastoma, neuroblastoma cells .a 1642 to 2462 840 to 20       821/840
(97 %)
14 diff
(98.4 %id)
BG683400 brain, neuroblastoma, cell line .a 1646 to 2468 870 to 1       867/874
(99 %)
39 diff
(95.6 %id)
TI_227713389   .a 1688 to 2523 894 to 64   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 831/993
(83 %)
9 diff
(99.1 %id)
BM550935 duodenal adenocarcinoma, cell line, small intestine .a 1750 to 2523 796 to 17   AAA Submitted on the opposite strand 780/1115
(69 %)
18 diff
(98.4 %id)
TI_149288175   .a 1754 to 2523 852 to 87   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 766/977
(78 %)
12 diff
(98.8 %id)
BM967242 Islets of Langerhans, Pancreas .a 1765 to 2293 1 to 530       530/530
(100 %)
1 diff
(99.9 %id)
CK823479 Islets of Langerhans, Pancreas .a 1765 to 2346 1 to 582       582/582
(100 %)
0 diff
(100 %id)
BM967113 Islets of Langerhans, Pancreas .a 1765 to 2248 1 to 484   fully sequenced,   484/484
(100 %)
0 diff
(100 %id)
AW387103 stomach .a 1780 to 2329 14 to 564       551/564
(97 %)
16 diff
(97.2 %id)
AW387108 stomach .a 1784 to 2406 1 to 634       634/634
(100 %)
39 diff
(93.9 %id)
BE810768 amnion_normal .a 1785 to 2123 1 to 344       344/344
(100 %)
19 diff
(94.5 %id)
TI_57162033   .a 1797 to 2520 22 to 746       725/802
(90 %)
7 diff
(99.2 %id)
BI832678 pooled pancreas and spleen .a 1801 to 2520 1 to 720       720/746
(96 %)
2 diff
(99.8 %id)
BQ014126 Chondrosarcoma, Left Pubic Bone .a 1811 to 2523 731 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 713/713
(100 %)
1 diff
(99.9 %id)
TI_154020501   .a 1821 to 2519 784 to 90   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 695/695
(100 %)
7 diff
(99.0 %id)
BX100877 placenta .a 1829 to 2049 1 to 221       221/221
(100 %)
0 diff
(100 %id)
R67677 placenta .a 1829 to 2181 1 to 363   fully sequenced,   363/363
(100 %)
7 diff
(98.1 %id)
CD367694 Alveolar Macrophage, lung .a 1834 to 2523 708 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 690/690
(100 %)
0 diff
(100 %id)
BG029741 breast, mammary adenocarcinoma, cell line .a 1884 to 2531 1 to 653       653/660
(98 %)
10 diff
(98.5 %id)
BU681259 lung .a 1893 to 2523 649 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 631/631
(100 %)
0 diff
(100 %id)
BU624672 cell lines, Enchondroma .a 1894 to 2523 648 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 630/630
(100 %)
0 diff
(100 %id)
BQ025012 placenta .a 1895 to 2516 640 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 622/622
(100 %)
0 diff
(100 %id)
AV724570 hypothalamus .a 1900 to 2498 16 to 614       599/652
(91 %)
4 diff
(99.4 %id)
AV722470 hypothalamus .a 1905 to 2525 1 to 618       618/685
(90 %)
8 diff
(98.9 %id)
CA438474 lung, Metastatic Chondrosarcoma .a 1905 to 2519 630 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 615/615
(100 %)
1 diff
(99.9 %id)
BX351106 Neuroblastoma Cot 25-normalized .a 1920 to 2514 593 to 1       593/593
(100 %)
39 diff
(93.5 %id)
AV723151 hypothalamus .a 1921 to 2494 32 to 601       570/659
(86 %)
17 diff
(97.5 %id)
H03065 placenta .a 1921 to 2239 15 to 337   fully sequenced,   323/337
(95 %)
11 diff
(96.8 %id)
BU738090 eye, lens .a 1930 to 2523 612 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 594/594
(100 %)
2 diff
(99.7 %id)
BU194240 bone marrow, from acute myelogenous leukemia .a 1937 to 2526 1 to 594       594/868
(68 %)
16 diff
(98.2 %id)
AA115361 uterus .a 1951 to 2523 573 to 1       573/573
(100 %)
5 diff
(99.2 %id)
AI360165 anaplastic oligodendroglioma, brain .a 2010 to 2516 520 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 507/507
(100 %)
1 diff
(99.9 %id)
CV573492 cornea, eye .a 2010 to 2523 553 to 40   AAA Submitted on the opposite strand 514/514
(100 %)
1 diff
(99.9 %id)
AA700762 liver and spleen .a 2016 to 2523 512 to 1       512/512
(100 %)
9 diff
(98.3 %id)
AI891114 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2019 to 2518 504 to 5       500/504
(99 %)
0 diff
(100 %id)
AI346739 adenocarcinoma, colon .a 2028 to 2523 496 to 1       496/496
(100 %)
0 diff
(100 %id)
BE535461 cervix .a 2028 to 2524 1 to 497       497/497
(100 %)
0 diff
(100 %id)
BG060118 brain, glioblastoma without EGFR amplification .a 2029 to 2523 494 to 1       494/494
(100 %)
2 diff
(99.6 %id)
BF941611 carcinoid, lung .a 2033 to 2520 490 to 3       488/490
(99 %)
0 diff
(100 %id)
DB576979 hypothalamus .a 2036 to 2523 1 to 488     Submitted on the opposite strand 488/488
(100 %)
0 diff
(100 %id)
DB518634 testis .a 2040 to 2523 1 to 485     Submitted on the opposite strand 485/485
(100 %)
1 diff
(99.8 %id)
N52435.
matches multiple genes
liver and spleen .a 2042 to 2523 484 to 2     also hits gene POLR2K 483/484
(99 %)
0 diff
(100 %id)
AW468341 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .a 2045 to 2523 479 to 1       479/479
(100 %)
3 diff
(99.4 %id)
BE502983 carcinoid, lung .a 2051 to 2523 473 to 1       473/473
(100 %)
2 diff
(99.6 %id)
BP396456 pancreatic islet .a 2052 to 2498 1 to 447     Submitted on the opposite strand 447/447
(100 %)
1 diff
(99.8 %id)
AI373735 Kidney .a 2054 to 2523 471 to 1       471/471
(100 %)
2 diff
(99.6 %id)
DB566789 hypothalamus .a 2056 to 2523 1 to 468     Submitted on the opposite strand 468/468
(100 %)
1 diff
(99.8 %id)
AI493775 uterus .a 2056 to 2523 468 to 1       468/468
(100 %)
1 diff
(99.8 %id)
TI_182940185   .a 2062 to 2523 542 to 81   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 462/1012
(45 %)
3 diff
(99.8 %id)
CN480756 Aveolar Macrophage, lung .a 2062 to 2523 480 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 462/495
(93 %)
3 diff
(99.4 %id)
AA476376   .a 2063 to 2287 1 to 224   fully sequenced, Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 224/224
(100 %)
2 diff
(99.2 %id)
DB528843 hippocampus .a 2066 to 2523 1 to 458     Submitted on the opposite strand 458/458
(100 %)
19 diff
(95.9 %id)
AW005762 anaplastic oligodendroglioma, brain .a 2068 to 2516 462 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 449/449
(100 %)
12 diff
(97.4 %id)
DB542495 hippocampus .a 2070 to 2521 1 to 452     Submitted on the opposite strand 452/454
(99 %)
1 diff
(99.8 %id)
DB516089 testis .a 2071 to 2514 1 to 445     Submitted on the opposite strand 445/447
(99 %)
3 diff
(99.4 %id)
AI683639 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2071 to 2516 446 to 1       446/446
(100 %)
0 diff
(100 %id)
AA814726 brain, substantia nigra .a 2073 to 2523 451 to 1       451/451
(100 %)
1 diff
(99.8 %id)
AI885010 anaplastic oligodendroglioma, brain .a 2079 to 2523 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AI767165 2 pooled tumors (clear cell type), Kidney .a 2081 to 2524 446 to 3       444/446
(99 %)
0 diff
(100 %id)
DB519889 testis .a 2086 to 2523 1 to 438     Submitted on the opposite strand 438/438
(100 %)
0 diff
(100 %id)
AA548360 germ cell tumor .a 2088 to 2518 431 to 3       429/431
(99 %)
0 diff
(100 %id)
BM662937 eye, RPE and Choroid .a 2088 to 2523 452 to 18   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 435/445
(97 %)
1 diff
(99.8 %id)
DB555046 hypothalamus .a 2089 to 2523 1 to 434     Submitted on the opposite strand 434/434
(100 %)
3 diff
(99.4 %id)
AL046899 uterus .a 2091 to 2523 1 to 433   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 433/433
(100 %)
0 diff
(100 %id)
AA743776 germinal center B cell .a 2091 to 2260 170 to 1       170/170
(100 %)
0 diff
(100 %id)
DB530782 hippocampus .a 2092 to 2523 1 to 433     Submitted on the opposite strand 433/433
(100 %)
5 diff
(98.9 %id)
AI201283   .a 2092 to 2522 434 to 4       431/434
(99 %)
0 diff
(100 %id)
AW083368 colon, moderately differentiated adenocarcinoma .a 2092 to 2515 448 to 25   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 424/424
(100 %)
6 diff
(98.6 %id)
AA861883   .a 2094 to 2524 432 to 2       431/432
(99 %)
0 diff
(100 %id)
BE206031 muscle, rhabdomyosarcoma .a 2094 to 2524 433 to 3   fully sequenced,   431/433
(99 %)
0 diff
(100 %id)
DB532480 hippocampus .a 2104 to 2523 1 to 420     Submitted on the opposite strand 420/420
(100 %)
1 diff
(99.8 %id)
DB561275 hypothalamus .a 2105 to 2523 1 to 419     Submitted on the opposite strand 419/419
(100 %)
1 diff
(99.8 %id)
AW337418 lymph node, lymphoma, follicular mixed small and largecell .a 2109 to 2518 413 to 4       410/413
(99 %)
0 diff
(100 %id)
BQ002300 Chondrosarcoma, Left Pelvis .a 2110 to 2523 432 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 414/414
(100 %)
0 diff
(100 %id)
DB510465 testis .a 2114 to 2523 1 to 410     Submitted on the opposite strand 410/410
(100 %)
8 diff
(98.1 %id)
DB533760 hippocampus .a 2114 to 2523 1 to 411     Submitted on the opposite strand 411/411
(100 %)
13 diff
(96.9 %id)
AA814703 brain, substantia nigra .a 2114 to 2523 426 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 411/411
(100 %)
5 diff
(98.8 %id)
H25420 breast .a 2123 to 2453 336 to 1       336/344
(97 %)
7 diff
(98.0 %id)
W86998 liver and spleen .a 2148 to 2523 383 to 6       378/389
(97 %)
0 diff
(100 %id)
AI350602   .a 2149 to 2516 369 to 1       369/369
(100 %)
4 diff
(99.0 %id)
R66077 placenta .a 2151 to 2522 378 to 1   fully sequenced,   378/378
(100 %)
6 diff
(98.5 %id)
AI982937 pooled germ cell tumors .a 2158 to 2523 366 to 1       366/366
(100 %)
4 diff
(99.0 %id)
H05508 whole brain .a 2166 to 2524 364 to 3       362/434
(83 %)
0 diff
(100 %id)
BE503933 carcinoid, lung .a 2168 to 2522 354 to 1       354/354
(100 %)
2 diff
(99.5 %id)
DB511465 testis .a 2172 to 2516 1 to 344     Submitted on the opposite strand 344/351
(98 %)
6 diff
(98.3 %id)
BE503925 pooled germ cell tumors .a 2180 to 2524 346 to 2       345/346
(99 %)
0 diff
(100 %id)
AI991196 colon, colonic mucosa from 3 patients with Crohn'sdisease .a 2182 to 2524 347 to 3       345/347
(99 %)
0 diff
(100 %id)
AI537115 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2207 to 2523 317 to 1       317/327
(96 %)
6 diff
(98.2 %id)
H03066 placenta .a 2209 to 2515 311 to 1   fully sequenced,   311/311
(100 %)
4 diff
(98.8 %id)
BM893814 Islets of Langerhans, Pancreas .a 2218 to 2524 307 to 1   fully sequenced,   307/307
(100 %)
3 diff
(99.1 %id)
AW071169 breast, four pooled high-grade tumors, including twoprimary tumors and two metastatic to ovary .a 2220 to 2524 309 to 5       305/309
(98 %)
0 diff
(100 %id)
AW611497 Kidney .a 2250 to 2520 276 to 1       276/276
(100 %)
11 diff
(96.1 %id)
AW515049 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2251 to 2523 273 to 1       273/273
(100 %)
3 diff
(99.0 %id)
AW514681 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 2252 to 2516 265 to 1       265/265
(100 %)
0 diff
(100 %id)
Z39938 brain, total brain .a 2255 to 2523 269 to 1       269/270
(99 %)
0 diff
(100 %id)
AW117417 pooled .a 2255 to 2524 275 to 6       270/275
(98 %)
0 diff
(100 %id)
AA746328 Kidney .a 2259 to 2523 265 to 1       265/265
(100 %)
0 diff
(100 %id)
CN394052 embryonic stem cells, cell lines H1, H7, andH9 .a 2265 to 2523 1 to 258   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 258/258
(100 %)
1 diff
(99.7 %id)
BG104594 adrenal cortex carcinoma, cell line, adrenal gland .a 2266 to 2523 1 to 258   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 258/258
(100 %)
0 diff
(100 %id)
AA476326   .a 2270 to 2523 269 to 16   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 254/254
(100 %)
0 diff
(100 %id)
AA812376 invasive tumor (cell line), Prostate .a 2290 to 2517 230 to 2       229/230
(99 %)
0 diff
(100 %id)
BI824079 pooled brain, lung, testis .a 2303 to 2523 1 to 222   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 222/222
(100 %)
1 diff
(99.6 %id)
BE247017 leukopheresis .a 2318 to 2523 206 to 1       206/206
(100 %)
7 diff
(96.7 %id)
AI142856 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 2334 to 2523 203 to 14   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 190/229
(82 %)
0 diff
(100 %id)
AA995241 pooled .a 2340 to 2520 182 to 2       181/182
(99 %)
0 diff
(100 %id)
N51510 multiple sclerosis lesions .a 2342 to 2524 184 to 1       184/184
(100 %)
1 diff
(99.5 %id)
AW768320 lymph node, lymphoma, follicular mixed small and largecell .a 2347 to 2523 193 to 16   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 178/178
(100 %)
4 diff
(97.8 %id)
BG059958 brain, glioblastoma without EGFR amplification .a 2371 to 2523 153 to 1       153/153
(100 %)
0 diff
(100 %id)
AW591428 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 2394 to 2523 155 to 27   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 129/129
(100 %)
1 diff
(99.3 %id)
GD150445   .a 2403 to 2518 1 to 116       116/129
(89 %)
2 diff
(98.5 %id)
AW079118 colon, juvenile granulosa tumor .a 2403 to 2523 121 to 1       121/121
(100 %)
0 diff
(100 %id)
GD154833   .a 2410 to 2523 9 to 122   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 114/122
(93 %)
0 diff
(100 %id)
GD155142   .a 2410 to 2523 9 to 122   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 114/122
(93 %)
0 diff
(100 %id)
DC316206 amygdala .b 1 to 510 1 to 511   tiling clone,   511/511
(100 %)
2 diff
(99.7 %id)
NM_001077526.2   .b 2 to 2370 1 to 2369 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2369/2369
(100 %)
0 diff
(100 %id)
DB445475 testis .b 23 to 444 1 to 424       424/424
(100 %)
10 diff
(97.7 %id)
BI907264 leukocyte .b 26 to 798 1 to 783       783/784
(99 %)
21 diff
(97.4 %id)
TI_57232681   .b 26 to 646 28 to 650       623/811
(76 %)
7 diff
(99.2 %id)
DA604126   .b 30 to 546 2 to 518   capped   517/517
(100 %)
0 diff
(100 %id)
DA917288 small intestine .b 30 to 610 2 to 582   capped   581/581
(100 %)
0 diff
(100 %id)
DA973303 synovial membrane tissue from rheumatioidarthritis .b 30 to 569 2 to 541   capped   540/550
(98 %)
3 diff
(99.5 %id)
DA990130 synovial membrane tissue from rheumatioidarthritis .b 30 to 584 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA254216 caudate nucleus .b 31 to 544 39 to 553   capped   515/552
(93 %)
0 diff
(100 %id)
DB175617 kidney, tumor tissue .b 32 to 592 2 to 565   capped   564/564
(100 %)
3 diff
(99.5 %id)
DA543680   .b 33 to 584 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA732675   .b 33 to 583 2 to 550   capped   549/549
(100 %)
6 diff
(99.0 %id)
DB123500 thymus .b 33 to 419 2 to 388   capped   387/387
(100 %)
0 diff
(100 %id)
DB202935 trachea .b 34 to 603 2 to 572   capped   571/572
(99 %)
3 diff
(99.5 %id)
AF289603   .b 39 to 2368 1 to 2331 A464G V465R E466G L467A V468G ... tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2331/2331
(100 %)
2 diff
(100.0 %id)
DA628352 Kidney .b 39 to 569 2 to 532   capped   531/541
(98 %)
1 diff
(99.9 %id)
BF665313 brain, primitive neuroectoderm .b 41 to 648 1 to 599       599/861
(69 %)
23 diff
(97.4 %id)
BI258388 cervical carcinoma cell line, cervix .b 41 to 674 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
BQ070218 brain, neuroblastoma, cell line .b 41 to 833 1 to 797       797/1055
(75 %)
11 diff
(99.0 %id)
DA061053 cerebellum .b 42 to 590 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BM469698 embryonal carcinoma, cell line, testis .b 42 to 705 1 to 664       664/1042
(63 %)
13 diff
(98.8 %id)
DB169971 kidney, tumor tissue .b 42 to 462 164 to 584   capped   421/591
(71 %)
1 diff
(99.9 %id)
DA258210 caudate nucleus .b 43 to 483 2 to 442   capped   441/441
(100 %)
0 diff
(100 %id)
DB466864 hippocampus .b 43 to 478 1 to 435       435/435
(100 %)
2 diff
(99.6 %id)
DB255587 uterus .b 43 to 602 2 to 564   capped   563/563
(100 %)
4 diff
(99.3 %id)
DA060155 cerebellum .b 44 to 621 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DB450631 testis .b 44 to 462 1 to 418       418/424
(98 %)
3 diff
(99.3 %id)
DA658497   .b 44 to 550 2 to 509   capped   508/508
(100 %)
2 diff
(99.7 %id)
DA812358 ovary, tumor tissue .b 44 to 621 2 to 579   capped   578/580
(99 %)
3 diff
(99.5 %id)
DB034375 testis .b 44 to 613 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
DA162158 amygdala .b 45 to 530 2 to 487   capped   486/486
(100 %)
0 diff
(100 %id)
DA838683 placenta .b 45 to 599 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA556300   .b 46 to 615 2 to 571   capped   570/570
(100 %)
0 diff
(100 %id)
BF307585 muscle, rhabdomyosarcoma .b 46 to 750 1 to 742       665/754
(88 %)
54 diff
(92.9 %id)
BP241330 Liver .b 47 to 602 1 to 557       557/559
(99 %)
17 diff
(97.0 %id)
BP241545 Liver .b 47 to 629 1 to 584       584/584
(100 %)
2 diff
(99.7 %id)
BP241852 Liver .b 47 to 622 1 to 576       576/576
(100 %)
8 diff
(98.7 %id)
BG825704 muscle, rhabdomyosarcoma .b 47 to 706 1 to 686       617/772
(79 %)
29 diff
(96.3 %id)
DA711787   .b 47 to 607 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA063420 cerebellum .b 48 to 612 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA345821 substantia nigra .b 48 to 630 2 to 585   capped   584/584
(100 %)
3 diff
(99.5 %id)
BI333069 cervical carcinoma cell line, cervix .b 48 to 828 1 to 781       781/784
(99 %)
8 diff
(99.0 %id)
DA690092   .b 48 to 596 2 to 550   capped   549/549
(100 %)
3 diff
(99.5 %id)
DA917013 small intestine .b 48 to 483 2 to 439   capped   438/438
(100 %)
2 diff
(99.6 %id)
DB134403 thymus .b 48 to 374 2 to 328   capped   327/327
(100 %)
0 diff
(100 %id)
DA052054   .b 49 to 510 2 to 463   capped   462/462
(100 %)
0 diff
(100 %id)
BX343336   .b 49 to 974 1 to 925       925/925
(100 %)
11 diff
(98.9 %id)
DA535861 heart .b 49 to 624 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
DA586025 lung .b 49 to 528 2 to 481   capped   480/480
(100 %)
1 diff
(99.8 %id)
DA624773 Kidney .b 50 to 596 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
CN394048 embryonic stem cells, DMSO-treated H9 cellline .b 51 to 526 1 to 476       476/476
(100 %)
4 diff
(99.2 %id)
BG751022 eye, normal pigmented retinal epithelium .b 51 to 813 1 to 764       764/764
(100 %)
4 diff
(99.5 %id)
BG753690 eye, normal pigmented retinal epithelium .b 51 to 869 1 to 818       818/839
(97 %)
16 diff
(98.1 %id)
DB050869 testis .b 51 to 600 2 to 551   capped   550/550
(100 %)
3 diff
(99.5 %id)
DA274491 corpus callosum .b 55 to 633 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA694964   .b 55 to 597 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DA695512   .b 55 to 502 2 to 449   capped   448/448
(100 %)
1 diff
(99.8 %id)
CN394053 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 56 to 498 1 to 443       443/443
(100 %)
4 diff
(99.1 %id)
DA930225 small intestine .b 56 to 623 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BF305223 muscle, rhabdomyosarcoma .b 58 to 687 1 to 634       634/767
(82 %)
16 diff
(98.0 %id)
DN996861 breast cancer, Mammary gland (cancer tissue) .b 58 to 789 1 to 732       732/732
(100 %)
4 diff
(99.5 %id)
DB178728 kidney, tumor tissue .b 58 to 613 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
BQ638376 eye, retina .b 60 to 663 1 to 604       604/604
(100 %)
0 diff
(100 %id)
DA551077   .b 61 to 573 2 to 514   capped   513/513
(100 %)
0 diff
(100 %id)
AL557412 T cells (Jurkat cell line), T cells from T cell leukemia .b 63 to 970 1 to 905       905/909
(99 %)
7 diff
(99.3 %id)
BX362466   .b 63 to 569 1 to 507       507/507
(100 %)
1 diff
(99.9 %id)
BF127597 leiomyosarcoma cell line, uterus .b 63 to 568 1 to 506       506/903
(56 %)
12 diff
(98.7 %id)
BM546329 ovary (pool of 3) .b 63 to 829 28 to 793       766/1107
(69 %)
8 diff
(99.3 %id)
DB453153 testis .b 65 to 557 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
DA578110   .b 65 to 590 2 to 528   capped   527/527
(100 %)
2 diff
(99.7 %id)
BI544489 brain, hippocampus .b 65 to 664 1 to 600       600/600
(100 %)
5 diff
(99.2 %id)
DA617158   .b 65 to 627 2 to 564   capped   563/563
(100 %)
1 diff
(99.9 %id)
BQ428476 leiomyosarcoma, uterus .b 66 to 834 1 to 774       774/917
(84 %)
24 diff
(97.4 %id)
CB128443 Liver .b 66 to 583 1 to 518       518/518
(100 %)
0 diff
(100 %id)
DA574588   .b 67 to 626 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
BQ924243 brain, neuroblastoma, cell line .b 67 to 962 1 to 911       911/915
(99 %)
13 diff
(98.6 %id)
DA643449   .b 67 to 528 2 to 463   capped   462/462
(100 %)
0 diff
(100 %id)
DA687720   .b 67 to 610 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA867528 Prostate .b 67 to 596 2 to 531   capped   530/530
(100 %)
0 diff
(100 %id)
DA976643 synovial membrane tissue from rheumatioidarthritis .b 67 to 349 2 to 284   capped   283/287
(98 %)
1 diff
(99.7 %id)
BI666829 brain, hypothalamus .b 68 to 735 1 to 667       667/669
(99 %)
7 diff
(99.0 %id)
CN394050 embryonic stem cells, cell lines H1, H7, andH9 .b 70 to 432 1 to 363       363/363
(100 %)
5 diff
(98.7 %id)
TI_44000443   .b 70 to 664 90 to 684       595/684
(86 %)
1 diff
(99.9 %id)
BX646401   .b 71 to 653 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BG395724 eye, retinoblastoma .b 71 to 656 1 to 590       590/878
(67 %)
19 diff
(97.9 %id)
BP304540   .b 71 to 655 1 to 581       583/581
(100 %)
7 diff
(98.8 %id)
TI_44343022   .b 72 to 735 129 to 791       663/793
(83 %)
4 diff
(99.5 %id)
CT002171 T-Lymphocytes .b 72 to 797 1 to 727       727/731
(99 %)
3 diff
(99.6 %id)
DB133193 thymus .b 72 to 623 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
CN394055 embryonic stem cells, DMSO-treated H9 cellline .b 73 to 717 1 to 645       645/645
(100 %)
0 diff
(100 %id)
DB490938 hypothalamus .b 73 to 403 1 to 329       329/354
(92 %)
25 diff
(93.0 %id)
DB495736 hypothalamus .b 73 to 584 1 to 510       510/510
(100 %)
1 diff
(99.9 %id)
DB505694 hypothalamus .b 73 to 575 1 to 501       501/501
(100 %)
1 diff
(99.9 %id)
DA840147 placenta .b 73 to 627 2 to 556   capped   555/555
(100 %)
1 diff
(99.9 %id)
DA963360 stomach .b 73 to 615 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
DB127503 thymus .b 73 to 617 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA005413   .b 74 to 623 2 to 551   capped   550/550
(100 %)
0 diff
(100 %id)
CB149417 Liver .b 74 to 527 1 to 454       454/454
(100 %)
0 diff
(100 %id)
BP301565   .b 74 to 644 1 to 571       571/582
(98 %)
6 diff
(99.0 %id)
DA012524 adrenal gland .b 75 to 623 2 to 551   capped   550/550
(100 %)
1 diff
(99.9 %id)
DA052557   .b 75 to 528 2 to 455   capped   454/454
(100 %)
0 diff
(100 %id)
DA132138 alzheimer cortex .b 75 to 642 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DA166229 amygdala .b 75 to 623 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA200999 brain .b 75 to 603 2 to 530   capped   529/529
(100 %)
0 diff
(100 %id)
DA267237 caudate nucleus .b 75 to 623 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BP212933 cerebrum .b 75 to 641 1 to 567       567/570
(99 %)
3 diff
(99.5 %id)
DA482932   .b 75 to 659 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA562511 heart .b 75 to 646 2 to 573   capped   572/580
(98 %)
2 diff
(99.7 %id)
DA568454 whole embryo, mainly head .b 75 to 793 2 to 729   capped   726/752
(96 %)
23 diff
(97.0 %id)
DA576924   .b 75 to 635 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA631693 Kidney .b 75 to 553 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
DA645784 mammary gland .b 75 to 808 2 to 739   capped   738/747
(98 %)
11 diff
(98.6 %id)
DA671883   .b 75 to 648 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
DA680269   .b 75 to 633 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DA696786   .b 75 to 645 2 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA711711   .b 75 to 640 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
DA763329 tongue .b 75 to 626 2 to 558   capped   557/557
(100 %)
5 diff
(99.2 %id)
DA784144 brain .b 75 to 650 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA942536 Spleen .b 75 to 528 2 to 456   capped   455/455
(100 %)
2 diff
(99.6 %id)
DA025139   .b 76 to 623 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
DB473726 hippocampus .b 76 to 531 1 to 456       456/456
(100 %)
2 diff
(99.6 %id)
DA953549 Spleen .b 76 to 648 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DB060412 testis .b 76 to 608 2 to 534   capped   533/533
(100 %)
0 diff
(100 %id)
DA130379 alzheimer cortex .b 77 to 630 2 to 555   capped   554/554
(100 %)
0 diff
(100 %id)
DA201488 brain .b 77 to 623 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
DA472850   .b 77 to 646 2 to 571   capped   570/572
(99 %)
2 diff
(99.7 %id)
BQ883761 melanotic melanoma, cell line, skin .b 77 to 833 1 to 760       760/920
(82 %)
9 diff
(99.1 %id)
DA613011   .b 77 to 645 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB024843 testis .b 77 to 620 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DB291939 uterus .b 77 to 649 2 to 574   capped   573/573
(100 %)
1 diff
(99.9 %id)
BE905139 epithelioid carcinoma, Pancreas .b 78 to 824 1 to 740       740/746
(99 %)
17 diff
(97.8 %id)
BC050626 Duodenum, adenocarcinoma .b 79 to 2361 1 to 2283 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2283/2283
(100 %)
1 diff
(100.0 %id)
BG115098 duodenal adenocarcinoma, cell line, small intestine .b 79 to 818 1 to 738       738/873
(84 %)
13 diff
(98.6 %id)
DA684975   .b 79 to 627 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
DA813914   .b 79 to 623 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA144490 amygdala .b 80 to 623 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA160060 amygdala .b 80 to 626 2 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DA342833 substantia nigra .b 80 to 623 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
DA579849   .b 80 to 631 2 to 553   capped   552/552
(100 %)
0 diff
(100 %id)
DA945064 Spleen .b 80 to 623 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
DB248513 uterus .b 80 to 618 2 to 540   capped   539/539
(100 %)
2 diff
(99.7 %id)
DB454454 testis .b 81 to 545 1 to 465       465/465
(100 %)
0 diff
(100 %id)
DA011814 adrenal gland .b 82 to 650 2 to 570   capped   569/569
(100 %)
0 diff
(100 %id)
DA553115   .b 82 to 623 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA670613   .b 82 to 671 2 to 591   capped   590/590
(100 %)
1 diff
(99.9 %id)
DA884108   .b 82 to 640 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DA941824 Spleen .b 82 to 676 2 to 596   capped   595/595
(100 %)
0 diff
(100 %id)
DA961213 Spleen .b 82 to 622 2 to 542   capped   541/541
(100 %)
1 diff
(99.9 %id)
DB058846 testis .b 82 to 552 2 to 472   capped   471/471
(100 %)
1 diff
(99.8 %id)
DB163722 thymus .b 82 to 656 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DA207847 brain .b 83 to 646 2 to 566   capped   565/573
(98 %)
2 diff
(99.7 %id)
BF026045 melanotic melanoma, skin .b 83 to 699 1 to 621       621/621
(100 %)
2 diff
(99.7 %id)
DA629967 Kidney .b 83 to 661 2 to 580   capped   579/579
(100 %)
0 diff
(100 %id)
DA711742   .b 83 to 623 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
BG177259 lymph, lymphoma, cell line .b 84 to 619 1 to 536       536/536
(100 %)
0 diff
(100 %id)
CR983494 T-Lymphocytes .b 84 to 664 1 to 581       581/583
(99 %)
1 diff
(99.9 %id)
CR998211 T-Lymphocytes .b 84 to 798 1 to 716       716/726
(98 %)
2 diff
(99.8 %id)
BP365771 lung .b 84 to 665 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
DA390898 thalamus .b 85 to 683 2 to 600   capped   599/599
(100 %)
1 diff
(99.9 %id)
DA541448 lung .b 85 to 623 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
CX872808 embryonic stem .b 85 to 843 1 to 759       759/759
(100 %)
0 diff
(100 %id)
DA620930   .b 85 to 669 2 to 586   capped   585/585
(100 %)
0 diff
(100 %id)
DA737007   .b 85 to 904 2 to 825   capped   824/850
(96 %)
11 diff
(98.8 %id)
DA866858 Prostate .b 85 to 445 2 to 362   capped   361/361
(100 %)
0 diff
(100 %id)
DA918579 small intestine .b 85 to 623 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA949041 Spleen .b 85 to 528 2 to 449   capped   448/448
(100 %)
6 diff
(98.7 %id)
DB135006 thymus .b 85 to 623 2 to 540   capped   539/539
(100 %)
0 diff
(100 %id)
DA482567   .b 86 to 657 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DA560995 heart .b 87 to 623 12 to 548   capped   537/537
(100 %)
0 diff
(100 %id)
BP272574   .b 87 to 667 1 to 581       581/581
(100 %)
5 diff
(99.2 %id)
BG105759 adrenal cortex carcinoma, cell line, adrenal gland .b 90 to 829 1 to 743       743/1122
(66 %)
24 diff
(97.9 %id)
BM922775 leukocyte .b 90 to 969 11 to 896       886/1049
(84 %)
39 diff
(96.3 %id)
BQ948044 epidermoid carcinoma, cell line, lung .b 90 to 829 13 to 756       744/932
(79 %)
8 diff
(99.2 %id)
AW410382 muscle, rhabdomyosarcoma .b 92 to 643 7 to 558     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 552/558
(98 %)
1 diff
(99.9 %id)
BQ218957 melanotic melanoma, skin .b 92 to 644 1 to 561       561/1059
(52 %)
21 diff
(98.1 %id)
AA446727   .b 94 to 589 1 to 494       494/494
(100 %)
8 diff
(98.4 %id)
CR746531 leiomyosarcoma, uterus .b 95 to 595 7 to 507       501/507
(98 %)
0 diff
(100 %id)
BI909862 leukocyte .b 95 to 798 1 to 713       711/713
(99 %)
19 diff
(97.4 %id)
TI_57238000   .b 95 to 798 67 to 779       711/779
(91 %)
12 diff
(98.5 %id)
AL523741 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 96 to 1198 1 to 1096       1096/1096
(100 %)
10 diff
(99.1 %id)
BU147139 brain, neuroblastoma, cell line .b 96 to 643 1 to 553       553/868
(63 %)
9 diff
(99.0 %id)
CR975969 T-Lymphocytes .b 96 to 674 1 to 579       579/581
(99 %)
1 diff
(99.9 %id)
BG421937 Kidney, renal cell adenocarcinoma .b 99 to 646 1 to 549       549/553
(99 %)
15 diff
(97.3 %id)
BQ073190 leukocyte .b 99 to 975 1 to 884       884/1064
(83 %)
15 diff
(98.6 %id)
BG259390 embryonal carcinoma, cell line, testis .b 100 to 833 1 to 733       736/794
(92 %)
20 diff
(97.5 %id)
BG392385 embryonal carcinoma, cell line, testis .b 100 to 899 1 to 805       805/1072
(75 %)
24 diff
(97.8 %id)
BQ706974 Spleen .b 100 to 833 1 to 741       741/949
(78 %)
27 diff
(97.2 %id)
DA944444 Spleen .b 100 to 642 2 to 544   capped   543/543
(100 %)
0 diff
(100 %id)
CX754438 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass .b 101 to 859 1 to 758     Submitted on the opposite strand 758/758
(100 %)
3 diff
(99.7 %id)
BG822885 adenocarcinoma cell line, colon .b 102 to 636 1 to 536       518/546
(94 %)
22 diff
(96.0 %id)
BG823054 adenocarcinoma cell line, colon .b 102 to 815 1 to 713       713/713
(100 %)
8 diff
(98.9 %id)
BM799629 eye, retinoblastoma .b 102 to 569 1 to 468       468/1392
(33 %)
1 diff
(100.0 %id)
BQ434354 leiomyosarcoma, uterus .b 102 to 829 1 to 732       732/899
(81 %)
9 diff
(99.0 %id)
BQ424526 melanotic melanoma, skin .b 103 to 565 1 to 468       468/920
(50 %)
12 diff
(98.7 %id)
DA348309 substantia nigra .b 104 to 660 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
BE784726 large cell carcinoma, lung .b 104 to 770 1 to 764       629/799
(78 %)
50 diff
(93.8 %id)
BU553654 ovary, teratocarcinoma, cell line .b 104 to 1016 31 to 945       915/946
(96 %)
6 diff
(99.4 %id)
DA603461   .b 104 to 877 2 to 775   capped   774/774
(100 %)
3 diff
(99.7 %id)
BX385229   .b 106 to 436 1 to 330       330/354
(93 %)
15 diff
(95.8 %id)
BF308811 muscle, rhabdomyosarcoma .b 108 to 820 1 to 717       717/927
(77 %)
12 diff
(98.8 %id)
CN394054 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 109 to 720 1 to 612       612/612
(100 %)
0 diff
(100 %id)
CN394056 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 111 to 800 1 to 690       690/690
(100 %)
0 diff
(100 %id)
AA436929   .b 121 to 665 1 to 543   fully sequenced,   543/543
(100 %)
6 diff
(98.9 %id)
BE778364 eye, retinoblastoma .b 121 to 814 1 to 693       693/1051
(65 %)
13 diff
(98.8 %id)
CN394049 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b 133 to 814 1 to 682       682/682
(100 %)
0 diff
(100 %id)
BI905779 leukocyte .b 134 to 904 1 to 779       779/1015
(76 %)
11 diff
(99.0 %id)
TI_57231732   .b 134 to 904 29 to 807       779/1043
(74 %)
10 diff
(99.1 %id)
DA733777   .b 135 to 633 2 to 500   capped   499/499
(100 %)
3 diff
(99.4 %id)
DA574686   .b 149 to 722 2 to 575   capped   574/574
(100 %)
1 diff
(99.9 %id)
TI_1948147016   .b 152 to 754 139 to 744       606/1260
(48 %)
8 diff
(99.4 %id)
TI_1948147017   .b 152 to 643 130 to 622       493/1273
(38 %)
31 diff
(97.6 %id)
TI_1948147333   .b 152 to 797 136 to 786       651/1160
(56 %)
15 diff
(98.8 %id)
TI_1948147334   .b 152 to 829 131 to 808       678/1324
(51 %)
6 diff
(99.6 %id)
TI_1948147661   .b 152 to 837 134 to 825       692/1225
(56 %)
16 diff
(98.7 %id)
TI_1948147662   .b 152 to 829 132 to 811       680/1278
(53 %)
3 diff
(99.8 %id)
TI_1948147988   .b 152 to 820 138 to 811       674/1196
(56 %)
14 diff
(98.9 %id)
TI_1948147989   .b 152 to 950 131 to 936       804/1273
(63 %)
18 diff
(98.6 %id)
TI_1948212651   .b 152 to 714 125 to 687       563/1408
(39 %)
9 diff
(99.4 %id)
TI_1948212652   .b 152 to 972 120 to 944       825/1317
(62 %)
20 diff
(98.5 %id)
TI_1948212933   .b 152 to 833 125 to 807       683/1404
(48 %)
24 diff
(98.3 %id)
TI_1948212934   .b 152 to 1056 124 to 1032   AAA   909/1289
(70 %)
28 diff
(97.9 %id)
TI_1948213211   .b 152 to 824 128 to 803       676/1489
(45 %)
13 diff
(99.2 %id)
TI_1948213212   .b 152 to 1020 125 to 993       869/1271
(68 %)
23 diff
(98.2 %id)
TI_1948213496   .b 152 to 833 130 to 815       686/1351
(50 %)
17 diff
(98.8 %id)
TI_1948213497   .b 152 to 1021 123 to 993       871/1268
(68 %)
12 diff
(99.1 %id)
CV023152 mixed .b 153 to 781 1 to 629       629/632
(99 %)
1 diff
(99.9 %id)
DQ630520   .b 153 to 1949 1 to 1797 exact     1797/1797
(100 %)
0 diff
(100 %id)
EL734708 mixed .b 153 to 819 1 to 665       665/665
(100 %)
2 diff
(99.7 %id)
BU528729 epidermoid carcinoma, cell line, lung .b 160 to 1089 1 to 931       931/931
(100 %)
10 diff
(99.0 %id)
AW403708 lymph .b 165 to 641 8 to 484       477/484
(98 %)
0 diff
(100 %id)
TI_154140426   .b 165 to 833 80 to 749       670/704
(95 %)
14 diff
(98.1 %id)
BG034213 breast, mammary adenocarcinoma, cell line .b 235 to 975 1 to 741       741/1115
(66 %)
15 diff
(98.7 %id)
BU169915 large cell carcinoma, lung .b 259 to 1057 20 to 819       800/896
(89 %)
8 diff
(99.2 %id)
BG422139 Kidney, renal cell adenocarcinoma .b 273 to 961 1 to 695       695/697
(99 %)
14 diff
(98.0 %id)
BG422987 Kidney, renal cell adenocarcinoma .b 273 to 802 1 to 532       532/537
(99 %)
11 diff
(98.0 %id)
BP302731   .b 312 to 909 2 to 591       590/611
(96 %)
17 diff
(97.3 %id)
DA482939   .b 313 to 893 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
BP252497 Kidney .b 328 to 909 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
BG109666 Bone, osteosarcoma, cell line .b 331 to 975 1 to 650       650/654
(99 %)
6 diff
(99.1 %id)
AA308452 colon .b 334 to 768 1 to 435       435/435
(100 %)
0 diff
(100 %id)
AW951726   .b 335 to 593 1 to 259       259/259
(100 %)
8 diff
(97.0 %id)
BE789852 large cell carcinoma, lung .b 339 to 903 1 to 563       563/563
(100 %)
2 diff
(99.7 %id)
BQ052546 blood, natural killer cells, cell line .b 340 to 1268 1 to 939       939/1001
(93 %)
15 diff
(98.6 %id)
DB166518 thyroid gland .b 344 to 1057 2 to 717   capped   716/752
(95 %)
11 diff
(98.6 %id)
CF552982 Pooled muscle (cardiac and skeletal) .b 397 to 1120 1 to 728       728/878
(82 %)
16 diff
(98.2 %id)
DN998438 bone marrow .b 397 to 1036 8 to 647       640/647
(98 %)
0 diff
(100 %id)
BM172162 choriocarcinoma, placenta .b 420 to 1119 1 to 701       701/701
(100 %)
15 diff
(97.9 %id)
BP255085 Kidney .b 435 to 1005 1 to 571       571/571
(100 %)
1 diff
(99.9 %id)
BE730953 choriocarcinoma, placenta .b 442 to 1175 1 to 727       727/916
(79 %)
20 diff
(97.9 %id)
W26093 eye, retina .b 461 to 804 40 to 383       317/383
(82 %)
18 diff
(95.4 %id)
CB528927 Aveolar Macrophage, lung .b 466 to 976 742 to 233   AAA   510/724
(70 %)
2 diff
(99.8 %id)
BG335111 choriocarcinoma, placenta .b 472 to 1200 1 to 728       728/856
(85 %)
29 diff
(96.7 %id)
BP303731   .b 486 to 1067 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BE901799 choriocarcinoma, placenta .b 491 to 1274 1 to 779       779/791
(98 %)
14 diff
(98.3 %id)
TI_57190328   .b 507 to 1266 50 to 808       759/759
(100 %)
2 diff
(99.8 %id)
BI856365 breast, mammary adenocarcinoma, cell line .b 508 to 1266 1 to 758       758/758
(100 %)
2 diff
(99.8 %id)
CV027753 mixed .b 516 to 1178 1 to 661       661/664
(99 %)
5 diff
(99.3 %id)
TI_1948077642   .b 516 to 1290 130 to 905       776/1133
(68 %)
13 diff
(98.9 %id)
TI_1948077643   .b 516 to 1317 132 to 937   AAA   806/1090
(73 %)
6 diff
(99.5 %id)
TI_1948077965   .b 516 to 1280 129 to 893       765/1090
(70 %)
3 diff
(99.8 %id)
TI_1948078284   .b 516 to 1279 130 to 891       764/1101
(69 %)
19 diff
(98.3 %id)
TI_1948078285   .b 516 to 1316 134 to 936       803/1080
(74 %)
8 diff
(99.3 %id)
TI_1948078614   .b 516 to 1049 128 to 664       537/1127
(47 %)
11 diff
(99.1 %id)
TI_1948078615   .b 516 to 1263 133 to 889       754/1155
(65 %)
9 diff
(99.3 %id)
BF960899 nervous_normal .b 581 to 1116 6 to 540       535/545
(98 %)
9 diff
(98.4 %id)
AA446598   .b 598 to 706 142 to 33       110/142
(77 %)
1 diff
(99.3 %id)
BG120725 adenocarcinoma, cell line, Liver .b 601 to 1288 1 to 687       687/939
(73 %)
12 diff
(98.8 %id)
DA130360 alzheimer cortex .b 611 to 1168 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AA496015   .b 615 to 704 126 to 36   fully sequenced,   91/126
(72 %)
2 diff
(98.5 %id)
DA348839 substantia nigra .b 648 to 1148 2 to 502   capped   501/501
(100 %)
1 diff
(99.9 %id)
DA688705   .b 726 to 1267 2 to 543   capped   542/542
(100 %)
1 diff
(99.9 %id)
BQ226950 melanotic melanoma, skin .b 743 to 1591 1 to 856       856/860
(99 %)
12 diff
(98.7 %id)
BP302292   .b 751 to 1332 1 to 581       581/581
(100 %)
3 diff
(99.5 %id)
BQ706886 Spleen .b 754 to 1655 1 to 912       912/927
(98 %)
20 diff
(97.9 %id)
BX370803   .b 782 to 1651 1 to 872       872/880
(99 %)
13 diff
(98.6 %id)
BF529315 anaplastic oligodendroglioma with 1p/19qloss, brain .b 860 to 1476 1 to 616       616/616
(100 %)
1 diff
(99.9 %id)
BP357980 mammary gland .b 861 to 1443 1 to 583       583/583
(100 %)
3 diff
(99.5 %id)
AW403805 lymph .b 864 to 1375 1 to 512       512/512
(100 %)
3 diff
(99.5 %id)
TI_154140640   .b 870 to 1572 79 to 780       702/706
(99 %)
15 diff
(97.9 %id)
BE545135 cervical carcinoma cell line, cervix .b 880 to 1541 1 to 651       651/673
(96 %)
19 diff
(97.2 %id)
DA569603 whole embryo, mainly head .b 926 to 1765 2 to 830   capped   829/836
(99 %)
13 diff
(98.5 %id)
BM689379 eye, optic nerve .b 933 to 1475 9 to 551     Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 543/551
(98 %)
1 diff
(99.9 %id)
BM050511 eye, normal pigmented retinal epithelium .b 976 to 1765 1 to 788       788/868
(90 %)
9 diff
(99.0 %id)
BX372442   .b 1047 to 1746 699 to 1       699/699
(100 %)
4 diff
(99.5 %id)
TI_1948212936   .b 1047 to 1953 1030 to 119       912/1302
(70 %)
30 diff
(97.7 %id)
TI_1948213214   .b 1047 to 1953 1024 to 117       908/1257
(72 %)
27 diff
(97.9 %id)
TI_1948213499   .b 1115 to 1953 965 to 121       845/1307
(64 %)
11 diff
(99.2 %id)
BG258895 embryonal carcinoma, cell line, testis .b 1119 to 1763 1 to 648       648/875
(74 %)
19 diff
(97.9 %id)
AW404276 lymph .b 1120 to 1384 1 to 265       265/265
(100 %)
4 diff
(98.5 %id)
TI_1948213498   .b 1142 to 1953 935 to 125       811/1250
(64 %)
11 diff
(99.2 %id)
TI_151774784   .b 1148 to 1911 122 to 880       759/768
(98 %)
14 diff
(98.2 %id)
TI_1948212935   .b 1153 to 1953 925 to 123       803/1246
(64 %)
12 diff
(99.1 %id)
TI_1948213213   .b 1201 to 1953 874 to 122       753/1239
(60 %)
14 diff
(98.9 %id)
FN145270 breast carcinoma .b 1217 to 1304 85 to 1     Submitted on the opposite strand 85/87
(97 %)
4 diff
(95.5 %id)
BP426209 small intestine .b 1217 to 1520 1 to 304     Submitted on the opposite strand 304/304
(100 %)
0 diff
(100 %id)
BP306330   .b 1218 to 1734 1 to 583       519/583
(89 %)
14 diff
(97.6 %id)
TI_1948212654   .b 1220 to 1953 854 to 119       736/1284
(57 %)
15 diff
(98.9 %id)
AL523740 brain, neuroblastoma cells, Neuroblastoma Cot 25-normalized .b 1320 to 2352 1029 to 1       1029/1029
(100 %)
8 diff
(99.3 %id)
TI_1948212653   .b 1387 to 1953 688 to 121       568/1291
(43 %)
9 diff
(99.4 %id)
BI027689 marrow .b 1420 to 1904 1 to 486       486/494
(98 %)
15 diff
(97.0 %id)
F11250 brain, total brain .b 1452 to 1748 1 to 296       296/296
(100 %)
1 diff
(99.7 %id)
AL579456 T cells (Jurkat cell line), T cells from T cell leukemia .b 1459 to 2315 866 to 14       853/877
(97 %)
7 diff
(99.3 %id)
BF896994 marrow .b 1559 to 1833 275 to 1     Submitted on the opposite strand 275/275
(100 %)
2 diff
(99.3 %id)
FN078001 breast carcinoma .b 1576 to 1652 1 to 80       80/80
(100 %)
2 diff
(97.5 %id)
CN394051 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .b 1613 to 2290 1 to 678       678/678
(100 %)
2 diff
(99.8 %id)
BU740316 eye, lens .b 1659 to 2368 728 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 710/710
(100 %)
1 diff
(99.9 %id)
BU623047 cell lines, Chondrosarcoma .b 1715 to 2366 668 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 650/654
(99 %)
6 diff
(99.1 %id)
BQ007980 Chondrosarcoma, Left Pelvis .b 1726 to 2368 659 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 641/641
(100 %)
2 diff
(99.7 %id)
BM999867 Fibrosarcoma .b 1727 to 2368 660 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 642/642
(100 %)
0 diff
(100 %id)
CA431771 Bone, Subchondral Bone .b 1727 to 2368 659 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 641/641
(100 %)
1 diff
(99.9 %id)
BX362465   .b 1763 to 2339 574 to 1       574/718
(79 %)
27 diff
(96.3 %id)
BM673035 eye, optic nerve .b 1791 to 2368 596 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 578/578
(100 %)
0 diff
(100 %id)
DB371711 ovary, tumor tissue .b 1801 to 2368 573 to 1       573/576
(99 %)
21 diff
(96.4 %id)
DB369578   .b 1818 to 2361 543 to 1       543/555
(97 %)
8 diff
(98.6 %id)
DB354965 whole embryo, mainly head .b 1833 to 2368 541 to 1       541/547
(98 %)
17 diff
(96.9 %id)
DB356264 whole embryo, mainly head .b 1835 to 2368 534 to 1       534/582
(91 %)
11 diff
(98.2 %id)
DB353545   .b 1845 to 2368 526 to 1       526/526
(100 %)
13 diff
(97.6 %id)
DB365759   .b 1845 to 2368 527 to 1       527/549
(95 %)
11 diff
(98.0 %id)
DB382585 thyroid gland .b 1845 to 2364 521 to 1       521/525
(99 %)
7 diff
(98.7 %id)
AW410383 muscle, rhabdomyosarcoma .b 1872 to 2361 508 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 490/490
(100 %)
6 diff
(98.8 %id)
DB321562 mammary gland .b 1888 to 2361 475 to 1       475/475
(100 %)
8 diff
(98.4 %id)
DB364263   .b 1894 to 2368 474 to 1       474/474
(100 %)
5 diff
(99.0 %id)
F08913 brain, total brain .b 2058 to 2368 311 to 1       311/311
(100 %)
0 diff
(100 %id)
DA832504 placenta .c 1 to 644 2 to 646   tiling clone, capped   645/646
(99 %)
8 diff
(98.8 %id)
BX332551 Neuroblastoma Cot 25-normalized .c 6 to 961 31 to 985   tiling clone,   955/985
(96 %)
3 diff
(99.7 %id)
BX332550 Neuroblastoma Cot 25-normalized .c 1161 to 2166 1012 to 9   tiling clone,   1004/1012
(99 %)
4 diff
(99.7 %id)
DB378732 placenta .c 1735 to 2209 471 to 1   tiling clone,   471/471
(100 %)
5 diff
(99.0 %id)
CF994436 Human Placenta, placenta .d 1 to 507 18 to 527   tiling clone,   510/752
(67 %)
11 diff
(98.6 %id)
BF306135 muscle, rhabdomyosarcoma .d 27 to 707 1 to 676       678/934
(72 %)
22 diff
(97.7 %id)
AL559571 T cells from T cell leukemia .d 28 to 843 1 to 817   tiling clone,   817/817
(100 %)
16 diff
(98.1 %id)
DA837300 placenta .d 41 to 450 2 to 411   capped   410/410
(100 %)
0 diff
(100 %id)
DB260148 uterus .d 41 to 600 2 to 561   tiling clone, capped   560/560
(100 %)
0 diff
(100 %id)
AL581163 T cells from T cell leukemia .d 1431 to 2250 818 to 1   tiling clone,   823/818
(100 %)
23 diff
(97.2 %id)
NM_022485.4   .e 1 to 2189 1 to 2189 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2189/2189
(100 %)
0 diff
(100 %id)
BX401377   .e 68 to 973 1 to 906   tiling clone,   906/906
(100 %)
17 diff
(98.2 %id)
AL713695 brain .e 80 to 2183 1 to 2104 exact tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2104/2104
(100 %)
0 diff
(100 %id)
BX337549 Placenta Cot 25-normalized .e 89 to 828 30 to 769       740/769
(96 %)
0 diff
(100 %id)
BC001674 Muscle, rhabdomyosarcoma .e 96 to 2180 1 to 2085 exact available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2085/2085
(100 %)
0 diff
(100 %id)
AK026058   .e 434 to 2180 1 to 1747   available from FLJ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 1747/1747
(100 %)
0 diff
(100 %id)
TI_1948078286   .e 814 to 1772 1086 to 122       965/1212
(79 %)
30 diff
(97.6 %id)
TI_1948077644   .e 897 to 1772 998 to 121       878/1208
(72 %)
9 diff
(99.3 %id)
TI_1948077966   .e 898 to 1772 995 to 123       873/1185
(73 %)
6 diff
(99.5 %id)
TI_1948078617   .e 898 to 1772 997 to 123       875/1218
(71 %)
17 diff
(98.7 %id)
TI_1948078616   .e 911 to 1772 992 to 117       876/1269
(69 %)
22 diff
(98.3 %id)
TI_1948077967   .e 979 to 1772 916 to 124       793/1164
(68 %)
20 diff
(98.3 %id)
BG683276 brain, neuroblastoma, cell line .e 1001 to 1346 1 to 346   fully sequenced,   346/346
(100 %)
1 diff
(99.8 %id)
TI_1948078287   .e 1046 to 1772 860 to 126       735/1241
(59 %)
22 diff
(98.3 %id)
BX401376   .e 1205 to 2151 947 to 1       947/947
(100 %)
2 diff
(99.8 %id)
TI_1948077645   .e 1205 to 1772 691 to 124       568/1241
(45 %)
2 diff
(99.9 %id)
BG683904 brain, neuroblastoma, cell line .e 1285 to 2139 859 to 1   fully sequenced,   859/859
(100 %)
15 diff
(98.3 %id)
BX337548 Placenta Cot 25-normalized .e 1348 to 2177 829 to 1       829/829
(100 %)
1 diff
(99.9 %id)
BX376105 Neuroblastoma Cot 25-normalized .e 1385 to 2136 762 to 1       759/824
(92 %)
21 diff
(97.5 %id)
BM784046 Ascites, stomach .e 1433 to 2081 1 to 649       649/649
(100 %)
0 diff
(100 %id)
BF796406 lymph, lymphoma, cell line .e 1478 to 2189 1 to 710   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 710/710
(100 %)
7 diff
(99.1 %id)
BQ005405 Chondrosarcoma, Left Pelvis .e 1513 to 2180 686 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 668/668
(100 %)
1 diff
(99.9 %id)
CB138817 Liver .f 1 to 411 1 to 411   tiling clone,   411/411
(100 %)
0 diff
(100 %id)
BG328934 adenocarcinoma cell line, colon .f 15 to 727 1 to 715       715/913
(78 %)
18 diff
(98.1 %id)
AY007098   .f 318 to 2063 1 to 1746   tiling clone,   1746/1748
(99 %)
1 diff
(100.0 %id)
TI_57162658   .g 1 to 719 31 to 748       718/748
(95 %)
3 diff
(99.6 %id)
BI836476 pooled pancreas and spleen .g 2 to 719 1 to 718   tiling clone,   718/718
(100 %)
3 diff
(99.6 %id)
BP328665 rectum .g 485 to 1065 1 to 581   tiling clone,   581/581
(100 %)
0 diff
(100 %id)
AK295891 hippocampus .h 1 to 1450 2 to 1451 exact tiling clone,   1451/1451
(100 %)
0 diff
(100 %id)
DC336231 hippocampus .h 1 to 554 2 to 555       555/555
(100 %)
0 diff
(100 %id)
BP281227 bone marrow .i 1 to 579 2 to 580 exact tiling clone,   580/582
(99 %)
2 diff
(99.7 %id)
BQ228797 embryonal carcinoma, cell line, testis .i 12 to 796 1 to 786 exact tiling clone,   786/870
(90 %)
11 diff
(98.8 %id)
DA894651 skeletal muscle .j 1 to 552 2 to 553 N64D tiling clone, capped   552/552
(100 %)
1 diff
(99.9 %id)
DA653150   .k 1 to 571 2 to 572 exact tiling clone, capped   571/572
(99 %)
2 diff
(99.7 %id)
AK298846   .l 1 to 1621 5 to 1625 exact tiling clone,   1625/1625
(100 %)
0 diff
(100 %id)
DA691821   .l 1 to 562 5 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
AA248659   .l 1001 to 1190 1 to 190       190/190
(100 %)
1 diff
(99.5 %id)
DB256047 uterus .m 1 to 558 2 to 559 G83S tiling clone, capped   558/558
(100 %)
2 diff
(99.7 %id)
TI_227713855   .n 1 to 818 891 to 90 G2W K3E P5X A6P P7C ... tiling clone, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 802/969
(82 %)
23 diff
(97.7 %id)
CD364611 Alveolar Macrophage, lung .n 207 to 818 630 to 19   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 612/612
(100 %)
0 diff
(100 %id)
AK128312 thymus .o-u 1 to 2965 2 to 2962 exact tiling clone, available from FLJ,   2962/2962
(100 %)
17 diff
(99.5 %id)
DB145127 thymus .o-u 1 to 479 2 to 480   capped   479/479
(100 %)
0 diff
(100 %id)
BG015566 placenta_normal .o-u 1486 to 1812 1 to 325   tiling clone,   325/325
(100 %)
4 diff
(98.8 %id)
CA427651 Bone, Subchondral Bone .o-u 1508 to 2111 604 to 2   tiling clone, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 603/606
(99 %)
0 diff
(100 %id)
DB345680 thymus .o-u 2746 to 2965 220 to 1       220/220
(100 %)
0 diff
(100 %id)
AK021608 whole embryo, mainly head .p-u 1 to 1963 2 to 1965 exact tiling clone, available from FLJ,   1965/1965
(100 %)
2 diff
(99.9 %id)
AU118121 whole embryo, mainly head .p-u 1 to 774 2 to 771 F72V capped   770/770
(100 %)
10 diff
(98.8 %id)
AW854011 colon .p-u 219 to 776 566 to 10 Q59P K83Q     557/566
(98 %)
7 diff
(98.8 %id)
BF848758 lung_normal .p-u 280 to 735 458 to 1 F96L F97V Y102N   Submitted on the opposite strand 458/458
(100 %)
5 diff
(99.0 %id)
CN360049 embryonic stem cells, DMSO-treated H9 cellline .p-u 1003 to 1426 1 to 424       424/424
(100 %)
1 diff
(99.8 %id)
AU144768 whole embryo, mainly head .p-u 1409 to 1963 554 to 1   tiling clone,   554/557
(99 %)
15 diff
(97.4 %id)
AA366838 Pancreas .p-u 1413 to 1643 1 to 231       231/231
(100 %)
0 diff
(100 %id)
AI937562 anaplastic oligodendroglioma, brain .p-u 1551 to 1963 413 to 1       413/413
(100 %)
5 diff
(98.8 %id)
AI888303 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .p-u 1783 to 2268 487 to 1   tiling clone,   487/487
(100 %)
9 diff
(98.2 %id)
BX109345 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .p-u 1837 to 2279 444 to 1   tiling clone, Submitted on the opposite strand 444/444
(100 %)
9 diff
(98.0 %id)
CU445412 epidermis .q 1 to 303 312 to 9 R99N L100T L101P tiling clone, Submitted on the opposite strand 304/313
(97 %)
0 diff
(100 %id)
TI_44460165   .r 1 to 878 96 to 977 Y44L K45*     884/982
(90 %)
16 diff
(98.4 %id)
BI518477 leukocyte .r 1 to 878 2 to 883 Y44L K45* tiling clone,   883/888
(99 %)
17 diff
(98.1 %id)
AW804566 uterus .r 332 to 719 14 to 402   tiling clone,   389/402
(96 %)
1 diff
(99.8 %id)
DB265528 uterus .s 1 to 387 206 to 592 exact tiling clone, capped   387/591
(65 %)
0 diff
(100 %id)
AI335842 uterus .t 1 to 369 369 to 1 exact tiling clone,   369/369
(100 %)
0 diff
(100 %id)
AA804529 germinal center B cell .t 51 to 322 272 to 1       272/272
(100 %)
0 diff
(100 %id)
AV745153 Pituitary .u-u 1 to 644 1 to 637 exact tiling clone,   637/689
(92 %)
28 diff
(96.0 %id)
AV722829 hypothalamus .va-u 1 to 609 1 to 603 exact tiling clone,   603/603
(100 %)
5 diff
(99.2 %id)
BF900744 marrow .vb-u 1 to 402 18 to 419 exact tiling clone,   402/419
(95 %)
0 diff
(100 %id)
AL517870 brain, neuroblastoma, neuroblastoma cells Gene MTMR14, variant not shown         This clone was ignored    
AL517871 brain, neuroblastoma, neuroblastoma cells Gene MTMR14, variant not shown         This clone was ignored    
DA958589 Spleen Gene MTMR14, variant not shown       capped Suspected internal deletion, this clone was ignored    
BU616619 Bone, Subchondral Bone Gene MTMR14, variant not shown       AAA Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o-u, .p-u, .q, .r, .s, .t, .u-u, .va-u, .vb-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC